Description
Join the global effort to move beyond COVID-19.
Ascada Research has partnered with Adagio Therapeutics to evaluate whether an injectable study drug is safe and effective in preventing COVID-19 infection. We are looking for unvaccinated, COVID-negative individuals who have never had COVID in the past. If you enroll, you may qualify for a vaccine exemption for medical reasons.
To be eligible you must:
- Have never tested positive for COVID-19
- You do not have any symptoms of COVID
- You are unvaccinated and do not plan to get the vaccine
- Agree to comply with study protocol for the duration of the study (14 months)
Ascada Research
www.AscadaHealth.org
(657) 214-3679
M-F 8am-4:30pm
Discussion
By posting you agree to the Terms and Privacy Policy.